1. Home
  2. IRIX

as of 12-31-2025 1:53pm EST

$1.14
$0.01
-1.01%
Stocks Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus Nasdaq

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Founded: 1989 Country:
United States
United States
Employees: N/A City: MOUNTAIN VIEW
Market Cap: 20.2M IPO Year: 1996
Target Price: N/A AVG Volume (30 days): 86.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.30 EPS Growth: N/A
52 Week Low/High: $0.78 - $1.87 Next Earning Date: 11-11-2025
Revenue: $50,647,000 Revenue Growth: 4.58%
Revenue Growth (this year): 9.61% Revenue Growth (next year): N/A

AI-Powered IRIX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 77.70%
77.70%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of IRIDEX Corporation (IRIX)

Buy
IRIX Dec 16, 2025

Avg Cost/Share

$1.01

Shares

2,000

Total Value

$2,019.80

Owned After

251,550

SEC Form 4

Buy
IRIX Dec 15, 2025

Avg Cost/Share

$0.00

Shares

20,000

Total Value

$0.00

Owned After

251,550

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Dec 2, 2025

Avg Cost/Share

$0.94

Shares

1,584

Total Value

$1,498.40

Owned After

90,320

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Nov 20, 2025

Avg Cost/Share

$0.96

Shares

5,760

Total Value

$5,529.60

Owned After

90,320

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Nov 19, 2025

Avg Cost/Share

$0.96

Shares

1,000

Total Value

$960.00

Owned After

90,320

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Nov 18, 2025

Avg Cost/Share

$0.94

Shares

2,133

Total Value

$2,005.02

Owned After

90,320

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Nov 17, 2025

Avg Cost/Share

$0.96

Shares

3,124

Total Value

$2,998.76

Owned After

90,320

Buy
IRIX Nov 17, 2025

Avg Cost/Share

$0.97

Shares

21,843

Total Value

$21,087.23

Owned After

251,550

SEC Form 4

Dizon Romeo R

Chief Financial Officer

Buy
IRIX Nov 14, 2025

Avg Cost/Share

$0.88

Shares

14,769

Total Value

$12,996.72

Owned After

90,320

SEC Form 4

Buy
IRIX Nov 14, 2025

Avg Cost/Share

$0.97

Shares

28,157

Total Value

$27,244.71

Owned After

251,550

SEC Form 4

Share on Social Networks: